Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 159

1.

Effects of Mindfulness-Based Cognitive Therapy on Body Awareness in Patients with Chronic Pain and Comorbid Depression.

de Jong M, Lazar SW, Hug K, Mehling WE, Hölzel BK, Sack AT, Peeters F, Ashih H, Mischoulon D, Gard T.

Front Psychol. 2016 Jun 30;7:967. doi: 10.3389/fpsyg.2016.00967. eCollection 2016.

2.

Lifetime suicidal ideation and attempt in adults with full major depressive disorder versus sustained depressed mood.

Yoo HJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Heo JY, Kim K, Jeon HJ.

J Affect Disord. 2016 Jun 6;203:275-280. doi: 10.1016/j.jad.2016.06.007. [Epub ahead of print]

PMID:
27314814
3.

Inflammatory cytokines in major depressive disorder: A case-control study.

Cassano P, Bui E, Rogers AH, Walton ZE, Ross R, Zeng M, Nadal-Vicens M, Mischoulon D, Baker AW, Keshaviah A, Worthington J, Hoge EA, Alpert J, Fava M, Wong KK, Simon NM.

Aust N Z J Psychiatry. 2016 Jun 16. pii: 0004867416652736. [Epub ahead of print] Review.

PMID:
27313138
4.

Reduced frontal-subcortical white matter connectivity in association with suicidal ideation in major depressive disorder.

Myung W, Han CE, Fava M, Mischoulon D, Papakostas GI, Heo JY, Kim KW, Kim ST, Kim DJ, Kim DK, Seo SW, Seong JK, Jeon HJ.

Transl Psychiatry. 2016 Jun 7;6(6):e835. doi: 10.1038/tp.2016.110.

5.

Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder.

Baek JH, Kim HJ, Fava M, Mischoulon D, Papakostas GI, Nierenberg A, Heo JY, Jeon HJ.

Psychiatry Investig. 2016 May;13(3):321-6. doi: 10.4306/pi.2016.13.3.321. Epub 2016 May 18.

6.

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.

Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, Nyer M, Cassano P, Mischoulon D, Alpert JE, Brown EN, Nock MK, Fava M, Cusin C.

J Clin Psychiatry. 2016 Jun;77(6):e719-25. doi: 10.4088/JCP.15m10056.

PMID:
27232360
7.

Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses.

Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng CH.

Am J Psychiatry. 2016 Jun 1;173(6):575-87. doi: 10.1176/appi.ajp.2016.15091228. Epub 2016 Apr 26.

PMID:
27113121
8.

Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.

Cusin C, Ionescu DF, Pavone KJ, Akeju O, Cassano P, Taylor N, Eikermann M, Durham K, Swee MB, Chang T, Dording C, Soskin D, Kelley J, Mischoulon D, Brown EN, Fava M.

Aust N Z J Psychiatry. 2016 Feb 18. pii: 0004867416631828. [Epub ahead of print]

PMID:
26893373
9.

Loss of sexual interest and premenstrual mood change in women with postpartum versus non-postpartum depression: A nationwide community sample of Korean adults.

Kim K, Hong JP, Cho MJ, Fava M, Mischoulon D, Lee DW, Heo JY, Jeon HJ.

J Affect Disord. 2016 Feb;191:222-9. doi: 10.1016/j.jad.2015.11.050. Epub 2015 Dec 2.

PMID:
26682491
10.

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.

Fava M, Johe K, Ereshefsky L, Gertsik LG, English BA, Bilello JA, Thurmond LM, Johnstone J, Dickerson BC, Makris N, Hoeppner BB, Flynn M, Mischoulon D, Kinrys G, Freeman MP.

Mol Psychiatry. 2015 Dec 8. doi: 10.1038/mp.2015.178. [Epub ahead of print]

PMID:
26643541
11.

Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study.

Mischoulon D, De Jong MF, Vitolo OV, Cusin C, Dording CM, Yeung AS, Durham K, Parkin SR, Fava M, Dougherty DD.

J Psychiatr Res. 2015 Nov;70:98-105. doi: 10.1016/j.jpsychires.2015.08.016. Epub 2015 Aug 29.

PMID:
26424428
12.

International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry.

Sarris J, Logan AC, Akbaraly TN, Paul Amminger G, Balanzá-Martínez V, Freeman MP, Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Parletta N, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN.

World Psychiatry. 2015 Oct;14(3):370-1. doi: 10.1002/wps.20223. No abstract available.

13.

Nutritional medicine as mainstream in psychiatry.

Sarris J, Logan AC, Akbaraly TN, Amminger GP, Balanzá-Martínez V, Freeman MP, Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN; International Society for Nutritional Psychiatry Research.

Lancet Psychiatry. 2015 Mar;2(3):271-4. doi: 10.1016/S2215-0366(14)00051-0. Epub 2015 Feb 25.

PMID:
26359904
14.

Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study.

Cassano P, Cusin C, Mischoulon D, Hamblin MR, De Taboada L, Pisoni A, Chang T, Yeung A, Ionescu DF, Petrie SR, Nierenberg AA, Fava M, Iosifescu DV.

Psychiatry J. 2015;2015:352979. doi: 10.1155/2015/352979. Epub 2015 Aug 19.

15.

Treatment Outcome in Depressed Latinos Predicted by Concomitant Psychosislike Symptoms.

Cassano P, Trinh NH, Chang T, Cusin C, Fisher L, Pedrelli P, Nyer M, Kim DJ, Alpert J, Mischoulon D.

J Nerv Ment Dis. 2015 Oct;203(10):769-73. doi: 10.1097/NMD.0000000000000365.

PMID:
26356091
16.

Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder.

Baek JH, Heo JY, Fava M, Mischoulon D, Nierenberg A, Hong JP, Roh S, Jeon HJ.

J Affect Disord. 2015 Nov 15;187:183-7. doi: 10.1016/j.jad.2015.08.006. Epub 2015 Aug 28. Erratum in: J Affect Disord. 2016 Mar 15;193:185-6.

PMID:
26342171
17.

Comparison of Initial Psychological Treatment Selections by US and Japanese Early-Career Psychiatrists for Patients with Major Depression: A Case Vignette Study.

Williams A, Nakagawa A, Sado M, Fujisawa D, Mischoulon D, Smith F, Mimura M, Sato Y.

Acad Psychiatry. 2016 Apr;40(2):235-41. doi: 10.1007/s40596-015-0398-6. Epub 2015 Aug 13.

18.

Review of Suicide Prevention Programs: Massachusetts, United States, in Comparison with Seoul.

Baek JH, Park JI, Ahn J, Roh SW, Heo JY, Fava M, Mischoulon D, Jeon HJ.

Psychiatry Investig. 2015 Jul;12(3):281-7. doi: 10.4306/pi.2015.12.3.281. Epub 2015 Jul 6. Review.

19.

Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.

Yoo I, Woo JM, Lee SH, Fava M, Mischoulon D, Papakostas GI, Kim EJ, Chung S, Ha JH, Jeon HJ.

J Affect Disord. 2015 Oct 1;185:24-30. doi: 10.1016/j.jad.2015.06.038. Epub 2015 Jun 25.

PMID:
26142691
20.

Novel approaches to study design and intervention for residual symptoms of MDD.

Mischoulon D.

J Clin Psychiatry. 2015 Jun;76(6):e815-7. doi: 10.4088/JCP.14com09451. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk